메뉴 건너뛰기




Volumn 49, Issue 8, 2009, Pages 1537-1539

Data safety monitoring boards: A word from a sponsor (NHLBI)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DATA SAFETY MONITORING BOARD; HUMAN; INFORMATION PROCESSING; MONITORING; NATIONAL HEALTH ORGANIZATION; PATIENT SAFETY; QUALITY CONTROL; SAFETY;

EID: 68149141131     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02184.x     Document Type: Article
Times cited : (3)

References (7)
  • 1
    • 68149090475 scopus 로고    scopus 로고
    • Bethesda (MD). NHLBI Health Information Center. [cited 2009 Apr 5]. Available from: URL
    • Funding & research. Bethesda (MD) : NHLBI Health Information Center [cited 2009 Apr 5]. Available from: URL: http://www.nhlbi.nih.gov/funding/ policies/index.htm
    • Funding & Research.
  • 3
    • 34748875876 scopus 로고    scopus 로고
    • A primer on data safety monitoring boards: Mission, methods, and controversies
    • Hicks LK, Laupacis A, Slutsky AS. A primer on data safety monitoring boards: mission, methods, and controversies. Intensive Care Med 2007 33 : 1815 18.
    • (2007) Intensive Care Med , vol.33 , pp. 1815-18
    • Hicks, L.K.1    Laupacis, A.2    Slutsky, A.S.3
  • 4
    • 34748860155 scopus 로고    scopus 로고
    • United States Department of Health and Human Services, Food and Drug Administration. Rockville (MD). FDA. [cited 2009 Apr 5]. Available from: URL
    • United States Department of Health and Human Services, Food and Drug Administration. Guidance for clinical trial sponsors. Establishment and operation of clinical trial data monitoring committees. Rockville (MD) : FDA 2006 [cited 2009 Apr 5]. Available from: URL: http://www.fda.gov/CBER/gdlns/ clintrialdmc.pdf
    • (2006) Guidance for Clinical Trial Sponsors. Establishment and Operation of Clinical Trial Data Monitoring Committees.
  • 5
    • 41949085462 scopus 로고    scopus 로고
    • When should data and safety monitoring committees share interim results in cardiovascular trials?
    • Borer JS, Gordon DJ, Geller NL. When should data and safety monitoring committees share interim results in cardiovascular trials? JAMA 2008 299 : 1710 12.
    • (2008) JAMA , vol.299 , pp. 1710-12
    • Borer, J.S.1    Gordon, D.J.2    Geller, N.L.3
  • 6
    • 68149135454 scopus 로고    scopus 로고
    • Objectivity in research, 7/14/95, NIH guide for grants and contracts, volume 24, number 25. [cited 2009 Apr 5]. Available from: URL
    • Objectivity in research, 7/14/95, NIH guide for grants and contracts, volume 24, number 25 [cited 2009 Apr 5]. Available from: URL: http://grants.nih.gov/grants/guide/notice-files/not95-179.htm
  • 7
    • 68149113250 scopus 로고    scopus 로고
    • NHLBI guidelines for avoiding conflicts of interest in multicenter clinical trials. [cited 2009 Apr 5]. Available from: URL
    • NHLBI guidelines for avoiding conflicts of interest in multicenter clinical trials [cited 2009 Apr 5]. Available from: URL: http://www.nhlbi.nih. gov/funding/policies/coi-res.htm


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.